Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
“Regarding the HPA axis, cortisol is one of the most potent anti-inflammatory hormones in the body (58); yet, in the context of chronic stress or depression, as noted above, the immune system can become glucocorticoid resistant.”
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
“It is therefore a prototype for some of the most effective anti-inflammatory drugs (Pace, Hu, & Miller, 2007; Rhen & Cidlowski, 2005).”
BackgroundCoutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
“…1 r ( s t t s g n a A.E. Coutinho, K.E. Chapman / Molecula eviewed; Perretti and Ahluwalia (2000), Necela and Cidlowski 2004), Yeager et al. (2004), Rhen and Cidlowski (2005), Smoak nd Cidlowski (2004), Tuckermann et al. (2005), Kleiman and uckermann (2007), Newton and Holden (2007) and De…”
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Neunert, C., Terrell, D. R., Arnold, D. M., Buchanan, G., Cines, D. B., Cooper, N., Cuker, A., Despotovic, J. M., George, J. N., Grace, R. F., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000966 · Cited by 1,406
“Side effects taken into consideration included hypertension, hyperglycemia, sleep and mood disturbances, gastric irritation or ulcer formation, glaucoma, myopathy, and osteoporosis.(45,58-60)”
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Tomazini, B. M., Maia, I. S., Cavalcanti, A. B., Berwanger, O., Rosa, R. G., Veiga, V. C., Avezum, A., Lopes, R. D., Bueno, F. R., Silva, M. V. A. O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17021 · Cited by 1,241
Villar, J., Ferrando, C., Martínez, D., Ambrós, A., Muñoz, T., Soler, J. A., Aguilar, G., Alba, F., González-Higueras, E., Conesa, L. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30417-5 · Cited by 1,199
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“Because of their powerful anti-inflammatory and immunosuppressive actions, glucocorticoids are one of the most widely prescribed drugs in the world today (3, 4).”
BackgroundSelf-citationPyroptosis: A new frontier in cancer
Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., Yu, T., Wu, X., Shi, Y., Ma, P., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109595 · Cited by 1,049
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
“…on GR function may lead to a feed-forward cascade, whereby increased inflammation through its effects of the GR undercuts the well-known ability of glucocorticoids to restrain inflammatory responses (Rhen and Cidlowski, 2005), leading to further increases in inflammation and reduced GR function.”
BackgroundGlucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Perretti, M., & D'Acquisto, F. (2009) · Nature Reviews Immunology · doi:10.1038/nri2470 · Cited by 915
“During inflammation, increased levels of cortisol dampen local and systemic inflammatory events, thereby favouring proper resolution of the inflammatory respons”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Reciprocal regulation of the neural and innate immune systems
Irwin, M. R., & Cole, S. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3042 · Cited by 910
“This effect is mediated by three mechanisms, namely: suppressive binding of the glucocorticoid receptor to gene promoter sequences; glucocorticoid receptor-mediated transcriptional induction of anti-inflammatory genes (such as NFKBIA , which encodes IκBα); and non-genomic antagonism of pro-inflammatory transcription f…”
BackgroundHow corticosteroids control inflammation: Quintiles Prize Lecture 2005
Barnes, P. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706736 · Cited by 838
“…mechanisms whereby corticosteroids suppress inflammation so effectively in asthma and other inflammatory disease, based on recent developments in understanding the fundamental mechanisms of gene transcription and cell signalling in inflammation (Barnes & Adcock, 2003; Rhen & Cidlowski, 2005).”
BackgroundYang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.027 · Cited by 872
“5 (22-78) 63 (38-74) 65 (46-73) Age subgroups (y) 0-15 0 of 50 (0%) 0 of 14 (0%) 0 of 25 (0%) 0 of 11 (0%) 16-59 18 of 50 (36%) 9 of 14 (64.”
Waljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830
Methylprednisolone Infusion in Early Severe ARDS
Meduri, G. U., Golden, E., Freire, A. X., Taylor, E., Zaman, M., Carson, S. J., Gibson, M., & Umberger, R. (2007) · Chest · doi:10.1378/chest.06-2100 · Cited by 787
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
“In contrast, increased norepinephrine production following stressor exposure induces NFκB activity that activates the immune system and increases cytokine production (Bierhaus et al, 2003).”
BackgroundInfluentialKhan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771
“Commonly recommended standard therapies for IBD-UC patients are corticosteroids [17], amino-salicylates [18,19], and immunosuppressive agents [20,21].”
BackgroundSocial regulation of gene expression in human leukocytes
Cole, S. W., Hawkley, L. C., Arevalo, J. M., Sung, C. Y., Rose, R. M., & Cacioppo, J. T. (2007) · Genome Biology · doi:10.1186/gb-2007-8-9-r189 · Cited by 745
“Cortisol activation of the glucocorticoid receptor (GR) exerts broad anti-inflammatory effects by inhibiting nuclear factor (NF)-κB/Rel transcription factors and other pro-inflammatory signaling pathways (for example, the Janus kinase-signal transducer and activator of transcription (JAK/STAT) and interferon response…”
BackgroundThe spectrum of inflammatory responses
Medzhitov, R. (2021) · Science · doi:10.1126/science.abi5200 · Cited by 718
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
“Phosphodiesterase (PDE) 4 inhibitors are now in clinical development for the treatment of COPD and severe asthma, and oral roflumilast is already marketed as the first anti-inflammatory drug for COPD.86 However, the oral dose is limited by side effects that are also due to PDE4 inhibition, including nausea, diarrhea,…”
BackgroundInfluentialRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationThe WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Domingo, P., Mur, I., Mateo, G. M., Gutierrez, M. D. M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., et al. (2021) · JAMA · doi:10.1001/jama.2021.11330 · Cited by 678
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
“Adrenal production of cortisol, a potent anti-inflammatory glucocorticoid hormone, is regulated by the hypothalamic–pituitary–adrenal (HPA) axi”
BackgroundNeuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 608
“Indeed, glucocorticoids, such as cortisol, are the most potent anti-inflammatory hormones in the body.(43) These effects are largely mediated by protein-protein interactions between the glucocorticoid receptor and relevant inflammatory signaling molecules including NF B.”
BackgroundDose-related patterns of glucocorticoid-induced side effects
Huscher, D., Thiele, K., Gromnica-Ihle, E., Hein, G., Demary, W., Dreher, R., Zink, A., & Buttgereit, F. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092163 · Cited by 604
Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
Rothenberg, M. E., Klion, A. D., Roufosse, F. E., Kahn, J. E., Weller, P. F., Simon, H.-U., Schwartz, L. B., Rosenwasser, L. J., Ring, J., Griffin, E. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070812 · Cited by 583
Torres, A., Sibila, O., Ferrer, M., Polverino, E., Menendez, R., Mensa, J., Gabarrús, A., Sellarés, J., Restrepo, M. I., Anzueto, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.88 · Cited by 571
Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
Benros, M. E., Waltoft, B. L., Nordentoft, M., Østergaard, S. D., Eaton, W. W., Krogh, J., & Mortensen, P. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1111 · Cited by 572
Therapeutic Mechanisms of Glucocorticoids
Vandewalle, J., Luypaert, A., De Bosscher, K., & Libert, C. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.10.010 · Cited by 548
Surjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551
“They are widely used to combat inflammatory and allergic disorders and their therapeutic effects have been mainly ascribed to their capacity to suppress the production of proinflammatory cytokines (Rhen and Cidlowski, 2005).”
BackgroundGlucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
“Glucocorticoid receptors (GR) Glucocorticoids diffuse across the cell membrane and bind to GR in the cytoplasm (Rhen and Cidlowski, 2005; Nicolaides et al., 2010).”
BackgroundReddy, T. E., Pauli, F., Sprouse, R. O., Neff, N. F., Newberry, K. M., Garabedian, M. J., & Myers, R. M. (2009) · Genome Research · doi:10.1101/gr.097022.109 · Cited by 543
Da Silva, J. A. P., Jacobs, J. W. G., Kirwan, J. R., Boers, M., Saag, K. G., Inês, L. B. S., de Koning, E. J. P., Buttgereit, F., Cutolo, M., Capell, H., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038638 · Cited by 522
Impact of Stress on Cancer Metastasis
Moreno-Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 510
The Science of Early Life Toxic Stress for Pediatric Practice and Advocacy
Johnson, S. B., Riley, A. W., Granger, D. A., & Riis, J. (2013) · Pediatrics · doi:10.1542/peds.2012-0469 · Cited by 469
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
“In addition, glucocorticoids have clear inhibitory effects on inflammation (Rhen and Cidlowski, 2005).”
BackgroundOne Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids
Cruz-Topete, D., & Cidlowski, J. A. (2015) · Neuroimmunomodulation · doi:10.1159/000362724 · Cited by 454
Self-citationTFOS DEWS II Sex, Gender, and Hormones Report
Sullivan, D. A., Rocha, E. M., Aragona, P., Clayton, J. A., Ding, J., Golebiowski, B., Hampel, U., McDermott, A. M., Schaumberg, D. A., Srinivasan, S., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.04.001 · Cited by 434
“steps of both the innate and adaptive immune responses [722].”
BackgroundSleep Loss Activates Cellular Inflammatory Signaling
Irwin, M. R., Wang, M., Ribeiro, D., Cho, H. J., Olmstead, R., Breen, E. C., Martinez-Maza, O., & Cole, S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.004 · Cited by 467
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
“Corticosteroids, such as glucocorticoids and dexamethasone, act as anti-inflammatory and immunomodulatory agents by inhibiting the synthesis of proinflammatory cytokines and driving lymphocyte cell death [122].”
BackgroundEuropean guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H. A., Calzavara Pinton, P., Christen‐Zäch, S., et al. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18345 · Cited by 426
“29 There are only few studies in adult and paediatric AE patients, despite the regular use of systemic glucocorticosteroids in clinical practice.”
BackgroundLucassen, P. J., Meerlo, P., Naylor, A. S., van Dam, A. M., Dayer, A. G., Fuchs, E., Oomen, C. A., & Czéh, B. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.08.003 · Cited by 449
“Thus, a clear bi-directional communication exists between the immune and neuroendocrine systems (Rhen and Cidlowski, 2005).”
BackgroundInteractions of the circadian CLOCK system and the HPA-axis
Nader, N., Chrousos, G. P., & Kino, T. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.011 · Cited by 449
Macrophages and the Recovery from Acute and Chronic Inflammation
Hamidzadeh, K., Christensen, S. M., Dalby, E., Chandrasekaran, P., & Mosser, D. M. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034348 · Cited by 437
Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V., Hochberg, R. B., McKay, L., Renoir, J.-M., Weigel, N. L., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.9 · Cited by 426
“Prolonged glucocorticoid therapy causes serious side effects (Rhen and Cidlowski, 2005).”
BackgroundSelf-citationArticular fibrocartilage - Why does hyaline cartilage fail to repair?
Armiento, A. R., Alini, M., & Stoddart, M. J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.015 · Cited by 408
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419
“Signaling pathways can fine-tune GR activity through various post-translational modifications including phosphorylation, ubiquitination, sumoylation, and acetylation (72, 121).”
BackgroundButtgereit, F., Doering, G., Schaeffler, A., Witte, S., Sierakowski, S., Gromnica-Ihle, E., Jeka, S., Krueger, K., Szechinski, J., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60132-4 · Cited by 405
Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397
The mechanisms, diagnosis, and management of severe asthma in adults
Holgate, S. T., & Polosa, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69288-x · Cited by 398
The cholinergic anti-inflammatory pathway: A critical review
Martelli, D., McKinley, M. J., & McAllen, R. M. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.12.007 · Cited by 384
“It is therefore uncertain howmuch of the enhanced inflammatory response could be attributed to removal of vagal efferents and how much to reduced glucocorticoid restraint on inflammatory processes (Rhen and Cidlowski, 2005).”
BackgroundImmune and Inflammatory Role in Renal Disease
Imig, J. D., & Ryan, M. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120028 · Cited by 356
Borges, R. S., Ortiz, B. L. S., Pereira, A. C. M., Keita, H., & Carvalho, J. C. T. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.038 · Cited by 339
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
Self-citationMeijvis, S. C., Hardeman, H., Remmelts, H. H., Heijligenberg, R., Rijkers, G. T., van Velzen-Blad, H., Voorn, G. P., van de Garde, E. M., Endeman, H., Grutters, J. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60607-7 · Cited by 366
Modulation of Macrophage Efferocytosis in Inflammation
Korns, D., Frasch, S. C., Fernandez-Boyanapalli, R., Henson, P. M., & Bratton, D. L. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00057 · Cited by 349
“For example, glucocorticoids with protean effects on inflammation also enhance efferocytosis (Rhen and Cidlowski, 2005).”
BackgroundKabata, H., Moro, K., Fukunaga, K., Suzuki, Y., Miyata, J., Masaki, K., Betsuyaku, T., Koyasu, S., & Asano, K. (2013) · Nature Communications · doi:10.1038/ncomms3675 · Cited by 348
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
Li, P., Zheng, Y., & Chen, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00460 · Cited by 346
“For example, anti-TNF treatment exacerbated diseases in almost all multiple sclerosis (MS) (Robinson et al., 2001).”
BackgroundImmune targets for therapeutic development in depression: towards precision medicine
Drevets, W. C., Wittenberg, G. M., Bullmore, E. T., & Manji, H. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00368-1 · Cited by 348
Glucocorticoid‐induced leucine zipper (GILZ): a new important mediator of glucocorticoid action
Ayroldi, E., & Riccardi, C. (2009) · The FASEB Journal · doi:10.1096/fj.09-134684 · Cited by 338
“Their therapeutic activity reflects the physiological effects of endogenous steroids (4, 5), although with greater potency and efficacy.”
BackgroundBiocompatible Materials for Continuous Glucose Monitoring Devices
Nichols, S. P., Koh, A., Storm, W. L., Shin, J. H., & Schoenfisch, M. H. (2013) · Chemical Reviews · doi:10.1021/cr300387j · Cited by 347
Chen, E., Miller, G. E., Kobor, M. S., & Cole, S. W. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.53 · Cited by 340
Busillo, J. M., & Cidlowski, J. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.005 · Cited by 339
Self-citationCytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Pathology of the torn rotator cuff tendon: REDUCTION IN POTENTIAL FOR REPAIR AS TEAR SIZE INCREASES
Matthews, T. J. W., Hand, G. C., Rees, J. L., Athanasou, N. A., & Carr, A. J. (2006) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.88b4.16845 · Cited by 331
Tumors induce de novo steroid biosynthesis in T cells to evade immunity
Mahata, B., Pramanik, J., van der Weyden, L., Polanski, K., Kar, G., Riedel, A., Chen, X., Fonseca, N. A., Kundu, K., Campos, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17339-6 · Cited by 326
Newton, R., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 328
“For the past half a century, glucocorticoids (corticosteroids or glucocorticosteroids) have been among the most effective and widely used medications for the treatment of inflammatory diseases (Rhen and Cidlowski, 2005; Barnes, 2006).”
BackgroundMyalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C., Arcos-Burgos, M., & Lidbury, B. (2019) · Diagnostics · doi:10.3390/diagnostics9030091 · Cited by 313
“Catecholamines have been found to regulate the synthesis of immune system mediators through β-adrenergic receptor stimulation [226], suggesting an alternative pathway that links the neuroendocrine and immunological systems.”
BackgroundZunszain, P. A., Hepgul, N., & Pariante, C. M. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_211 · Cited by 303
Mechanisms and resistance in glucocorticoid control of inflammation
Barnes, P. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.018 · Cited by 317
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
Hypertension in rheumatoid arthritis
Panoulas, V. F., Metsios, G. S., Pace, A. V., John, H., Treharne, G. J., Banks, M. J., & Kitas, G. D. (2008) · Rheumatology · doi:10.1093/rheumatology/ken159 · Cited by 303
Seropian, I. M., Toldo, S., Van Tassell, B. W., & Abbate, A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.014 · Cited by 296
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Vandevyver, S., Dejager, L., Tuckermann, J., & Libert, C. (2013) · Endocrinology · doi:10.1210/en.2012-2045 · Cited by 296
“The consensus GRE sequence is an inverted imperfect hexameric palindrome separated by a spacer of 3 bp (5 -AGAACAnnnTGTTCT-3 , in which “n” is any nucleotide) (5, 27).”
BackgroundToxic Stress in Children and Adolescents
Bucci, M., Marques, S. S., Oh, D., & Harris, N. B. (2016) · Advances in Pediatrics · doi:10.1016/j.yapd.2016.04.002 · Cited by 295
Hannan, T. J., Mysorekar, I. U., Hung, C. S., Isaacson-Schmid, M. L., & Hultgren, S. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001042 · Cited by 287
“Specifically, they block the production of acute mediators of inflammation such as TNFa, IL-1, IL-6, and arachidonic acid derivatives such as prostaglandins and leukotrienes, in part through blockade of NF-kB activity [58].”
BackgroundBarnes, P. J. (2010) · Pharmaceuticals · doi:10.3390/ph3030514 · Cited by 277
“There have been major advances in understanding the molecular mechanisms whereby ICS suppress inflammation in asthma, based on recent developments in understanding the fundamental mechanisms of gene transcription [1,2].”
BackgroundInterplay between the gut-brain axis, obesity and cognitive function
Agustí, A., García-Pardo, M. P., López-Almela, I., Campillo, I., Maes, M., Romaní-Pérez, M., & Sanz, Y. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00155 · Cited by 294
“In this situation the HPA-axis produces GCs, which in the periphery modify metabolic and developmental processes, and suppress the pro-inflammatory and antiviral immune response in the short-term (Besedovsky et al., 1986; Berkenbosch et al., 1987; Sapolsky et al., 1987; Rhen and Cidlowski, 2005).”
BackgroundBlack, P. H. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.008 · Cited by 276
“Cortisol potentiates downstream a1-adrenergic signaling [8].”
Autonomic dysreflexia after spinal cord injury: Systemic pathophysiology and methods of management
Eldahan, K. C., & Rabchevsky, A. G. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2017.05.002 · Cited by 276
“GCs subsequently bind to the intracellular glucocorticoid receptor in leukocytes to alter the transcriptional programming and limit inflammatory responses (reviewed in Rhen and Cidlowski, 2005).”
BackgroundCurrent status of potential therapeutic candidates for the COVID-19 crisis
Zhang, J., Xie, B., & Hashimoto, K. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.046 · Cited by 283
Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
De Bosscher, K., & Haegeman, G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0283 · Cited by 284
Doloff, J. C., Veiseh, O., Vegas, A. J., Tam, H. H., Farah, S., Ma, M., Li, J., Bader, A., Chiu, A., Sadraei, A., et al. (2017) · Nature Materials · doi:10.1038/nmat4866 · Cited by 283
Stern, A., Skalsky, K., Avni, T., Carrara, E., Leibovici, L., & Paul, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007720.pub3 · Cited by 271
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
Mueller, A.-L., Payandeh, Z., Mohammadkhani, N., Mubarak, S. M. H., Zakeri, A., Alagheband Bahrami, A., Brockmueller, A., & Shakibaei, M. (2021) · Cells · doi:10.3390/cells10113017 · Cited by 256
Severe asthma in adults: What are the important questions?
Chanez, P., Wenzel, S. E., Anderson, G. P., Anto, J. M., Bel, E. H., Boulet, L.-P., Brightling, C. E., Busse, W. W., Castro, M., Dahlen, B., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.702 · Cited by 277
The osteocyte as a signaling cell
Delgado-Calle, J., & Bellido, T. (2022) · Physiological Reviews · doi:10.1152/physrev.00043.2020 · Cited by 261
Anti-inflammatory functions of glucocorticoid-induced genes
Clark, A. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.013 · Cited by 274
“Effects of GCs on gene expression are mediated by the GC receptor (GR), a member of a large family of nuclear hormone receptor transcription factors (Newton, 2000; Rhen and Cidlowski, 2005).”
BackgroundTargeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Skytthe, M. K., Graversen, J. H., & Moestrup, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155497 · Cited by 261
Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women
Hackett, R. A., Hamer, M., Endrighi, R., Brydon, L., & Steptoe, A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.016 · Cited by 272
“Cortisol is involved in regulating inflammation through activation of the glucocorticoid (GC) receptor mechanisms, leading to inhibition of pro-inflammatory signalling pathways (Raison and Miller, 2003; Rhen and Cidlowski, 2005).”
BackgroundRelative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe Asthma
Hew, M., Bhavsar, P., Torrego, A., Meah, S., Khorasani, N., Barnes, P. J., Adcock, I., & Fan Chung, K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1930oc · Cited by 271
“Corticosteroids are likely to inhibit the expression of these cytokines through the reversal of histone acetylation at the site of the cytokine gene expression by direct binding of the activated corticosteroid receptor to NF- B– associated coactivators or by recruitment of HDACs to the activated transcription complex…”
BackgroundMultiple glucocorticoid receptor isoforms and mechanisms of post-translational modification
Duma, D., Jewell, C. M., & Cidlowski, J. A. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.009 · Cited by 267
Self-citation
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.